Form 4: Core Scientific CEO Adam Sullivan Acquires Shares Through Vesting, Sells to Cover Taxes

Sentiment:

SEC Form 4 Filing


Core Scientific's CEO, Adam Sullivan, acquired 159,306 shares through vesting of restricted stock units and sold 88,380 shares to cover tax obligations.

Summary

  • Core Scientific CEO Adam Sullivan acquired 159,306 shares of common stock on December 31, 2024, through the vesting of performance-based restricted stock units.
  • These restricted stock units were part of a grant from June 14, 2024, and vested at 300% of the first installment.
  • On January 2, 2025, Mr. Sullivan sold 88,380 shares at a price of $14.243 per share.
  • The sale was to cover tax obligations arising from the vesting of the restricted stock units.
  • Following these transactions, Mr. Sullivan beneficially owns 4,128,505 shares of Core Scientific common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction of stock vesting and sale for tax purposes. While the sale might cause minor concern, the overall sentiment is neutral to slightly positive due to the vesting indicating performance achievement.

Positives

  • The vesting of performance-based restricted stock units indicates that performance targets were met, which is a positive sign for the company.
  • The CEO's continued significant shareholding demonstrates his alignment with the company's success.

Negatives

  • The sale of 88,380 shares, while for tax purposes, could be perceived negatively by some investors as a reduction in the CEO's stake.

Risks

  • The sale of shares by an executive, even for tax purposes, can sometimes create short-term price volatility.
  • The market may interpret the sale as a lack of confidence, despite the explanation provided.

Industry Context

This type of transaction is common for executives who receive stock-based compensation. The sale to cover taxes is a standard practice.

Comparison to Industry Standards

  • Executive stock transactions are a common occurrence in publicly traded companies, particularly in the technology sector.
  • Similar transactions are frequently seen at companies like Marathon Digital Holdings (MARA) and Riot Platforms (RIOT), where executives often receive stock options and restricted stock units as part of their compensation packages.
  • The vesting and subsequent sale for tax purposes is a standard practice across the industry.

Stakeholder Impact

  • Shareholders may have a neutral reaction to this news, as it is a common practice for executives to sell shares to cover taxes after vesting.
  • Employees may view the vesting as a positive sign of the company's performance.

Key Dates

DateDescription
06/14/2024Date of the original grant of performance-based restricted stock units.
12/31/2024Date of acquisition of 159,306 shares due to vesting of restricted stock units.
01/02/2025Date of sale of 88,380 shares to cover tax obligations.
01/03/2025Date of filing of the Form 4.

Keywords

Core Scientific, Adam Sullivan, stock vesting, restricted stock units, insider trading, tax obligations, share sale, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.